Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab

Francisca Llinares-Tello; José Rosas-Gómez de Salazar; José Miguel Senabre-Gallego; Gregorio Santos-Soler; Carlos Santos-Ramírez; Esteban Salas-Heredia; Juan Molina-García

doi:10.1515/cclm-2012-0050

Show Summary Details

More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter

IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

See all formats and pricing

Online
ISSN: 1437-4331

Online: Institutional Subscription
€ [D] 2074.00 / US$ 3108.00 / GBP 1700.00*
Individual Subscription
€ [D] 249.00 / US$ 374.00 / GBP 205.00*
Print: Institutional Subscription
€ [D] 2074.00 / US$ 3108.00 / GBP 1700.00*
Individual Subscription
€ [D] 2074.00 / US$ 3108.00 / GBP 1700.00*
Print + Online: Institutional Subscription
€ [D] 2489.00 / US$ 3729.00 / GBP 2040.00*
Individual Subscription
€ [D] 2489.00 / US$ 3729.00 / GBP 2040.00*

*Prices in US$ apply to orders placed in the Americas only. Prices in GBP apply to orders placed in Great Britain only. Prices in € represent the retail prices valid in Germany (unless otherwise indicated). Prices are subject to change without notice. Prices do not include postage and handling if applicable. RRP: Recommended Retail Price.

More options …

Ahead of print

Most Downloaded Articles
Diabetes as a complication of adipose tissue dysfunction. Is there a role for potential new biomarkers? by Bergmann, Katarzyna and Sypniewska, Grazyna
Joint EFLM-COLABIOCLI Recommendation for venous blood sampling by Simundic, Ana-Maria/ Bölenius, Karin/ Cadamuro, Janne/ Church, Stephen/ Cornes, Michael P./ van Dongen-Lases, Edmée C./ Eker, Pinar/ Erdeljanovic, Tanja/ Grankvist, Kjell/ Guimaraes, Joao Tiago/ Hoke, Roger/ Ibarz, Mercedes/ Ivanov, Helene/ Kovalevskay...
Unexpected high plasma cobalamin/Proposal for a diagnostic strategy by Arendt, Johan F.B. and Nexo, Ebba
Congress of Clinical Chemistry and Laboratory Medicine
Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use by Schuetz, Philipp/ Beishuizen, Albertus/ Broyles, Michael/ Ferrer, Ricard/ Gavazzi, Gaetan/ Gluck, Eric Howard/ González del Castillo, Juan/ Jensen, Jens-Ulrik/ Kanizsai, Peter Laszlo/ Kwa, Andrea Lay Hoon/ Krueger, Stefan/ Luyt, Charles-Edouard/ Oppert...
Theranos phenomenon: promises and fallacies by Diamandis, Eleftherios P.
Recent advances in physiological lipoprotein metabolism by Ramasamy, Indra
Current and future use of “dried blood spot” analyses in clinical chemistry by Lehmann, Sylvain/ Delaby, Constance/ Vialaret, Jérôme/ Ducos, Jacques and Hirtz, Christophe
Reticulated platelets: analytical aspects and clinical utility by Hoffmann, Johannes J.M.L.
Lactic acidosis: an update by Seheult, Jansen/ Fitzpatrick, Gerard and Boran, Gerard
Congress of Clinical Chemistry and Laboratory Medicine / 10th Annual Meeting of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL), Dresden, Germany, 23rd–26th October, 2013*)
Abstracts IV Italian Great Network CongressRome, 14th–18th October 2013*)
Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management by Kounis, Nicholas G.
Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage? by Nagy, Karin/ Skagervik, Ina/ Tumani, Hayrettin/ Petzold, Axel/ Wick, Manfred/ Kühn, Hans-Jürgen/ Uhr, Manfred/ Regeniter, Axel/ Brettschneider, Johannes/ Otto, Markus/ Kraus, Jörg/ Deisenhammer, Florian/ Lautner, Ronald/ Blennow, Kaj/ Shaw, Leslie/ Zet...
The 3rd EFLM-UEMS Congress
Preanalytical quality improvement: in quality we trust by Lippi, Giuseppe/ Becan-McBride, Kathleen/ Behúlová, Darina/ Bowen, Raffick A./ Church, Stephen/ Delanghe, Joris/ Grankvist, Kjell/ Kitchen, Steve/ Nybo, Mads/ Nauck, Matthias/ Nikolac, Nora/ Palicka, Vladimir/ Plebani, Mario/ Sandberg, Sverre and Simun...
Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption by Kashani, Kianoush/ Cheungpasitporn, Wisit and Ronco, Claudio
Frontmatter
Epigenetic mechanisms in bone by Vrtačnik, Peter/ Marc, Janja and Ostanek, Barbara
Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias by Willrich, Maria A.V. and Katzmann, Jerry A.
Most Downloaded Articles

Submission of Manuscripts

Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab

Francisca Llinares-Tello

Corresponding author
Laboratory Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
Email
Other articles by this author:
De Gruyter Online Google Scholar

/ José Rosas-Gómez de Salazar

Rheumatology Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
Other articles by this author:
De Gruyter Online Google Scholar

/ José Miguel Senabre-Gallego

Rheumatology Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
Other articles by this author:
De Gruyter Online Google Scholar

/ Gregorio Santos-Soler

Rheumatology Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
Other articles by this author:
De Gruyter Online Google Scholar

/ Carlos Santos-Ramírez

Rheumatology Department, Marina Salud Hospital, Denia, Alicante, Spain
Other articles by this author:
De Gruyter Online Google Scholar

/ Esteban Salas-Heredia

Rheumatology Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
Other articles by this author:
De Gruyter Online Google Scholar

/ Juan Molina-García

Laboratory Department, Marina Baixa Hospital, Villajoyosa, Alicante, Spain
Other articles by this author:
De Gruyter Online Google Scholar

Published Online: 2012-03-26 | DOI: https://doi.org/10.1515/cclm-2012-0050

30,00 € / $42.00 / £23.00

Get Access to Full Text

About the article

Corresponding author: Francisca Llinares-Tello c/o Colón 120 2°A, 03570, Villajoyosa, Alicante, Spain

Received: 2012-01-25

Accepted: 2012-03-09

Published Online: 2012-03-26

Published in Print: 2012-10-01

Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 50, Issue 10, Pages 1845–1847, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2012-0050.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]

Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis

José Miguel Senabre Gallego, Jose Rosas, Mariana Marco-Mingot, José Alberto García-Gómez, Gregorio Santos-Soler, Esteban Salas-Heredia, Ana Pons-Bas, Xavier Barber-Vallés, José Antonio Bernal-Vidal, Catalina Cano-Pérez, Mario García-Carrasco, and Emilio Flores-Pardo

Rheumatology International, 2019, Volume 39, Number 5, Page 841

DOI: 10.1007/s00296-019-04288-7

[2]

Prevalence of TNF-α Blocker Immunogenicity in Psoriatic Arthritis

Michael Zisapel, Devy Zisman, Noa Madar-Balakirski, Uri Arad, Hagit Padova, Hagit Matz, Hagit Maman-Sarvagyl, Ilana Kaufman, Daphna Paran, Joy Feld, Ira Litinsky, Irena Wigler, Dan Caspi, and Ori Elkayam

The Journal of Rheumatology, 2015, Volume 42, Number 1, Page 73

DOI: 10.3899/jrheum.140685

[3]

Reliability evaluation of four different assays for therapeutic drug monitoring of infliximab levels

Irene Pérez, Lidia Fernández, Silvia Sánchez-Ramón, Cristina Alba, Ana Zatarain, Mercedes Cañas, Olga N. López, David Olivares, Enrique Rey, and Carlos Taxonera

Therapeutic Advances in Gastroenterology, 2018, Volume 11, Page 175628481878361

DOI: 10.1177/1756284818783613

[4]

Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice

Mariam Aguas Peris, Virginia Bosó, Belén Navarro, Maria R. Marqués-Miñana, Guillermo Bastida, Belén Beltrán, Marisa Iborra, Esteban Sáez-González, Emilio Monte-Boquet, Jose L. Poveda-Andrés, and Pilar Nos

Inflammatory Bowel Diseases, 2017, Volume 23, Number 8, Page 1454

DOI: 10.1097/MIB.0000000000001182

[5]

Positive correlation between etanercept concentration and the decrease in Psoriasis Area and Severity Index scale value

Laida Elberdín, Maria Outeda, Pilar Salvador, Sabela Paradela, Rosa María Fernández-Torres, Raquel Iglesias, Eduardo Fonseca, and Isabel Martín

International Journal of Clinical Pharmacy, 2016, Volume 38, Number 5, Page 1142

DOI: 10.1007/s11096-016-0343-0

[6]

Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: a comprehensive overview of methodology pitfalls and benefits

Manca Ogrič, Matic Terčelj, Sonja Praprotnik, Matija Tomšič, Borut Božič, Snezna Sodin-Semrl, and Saša Čučnik

Immunologic Research, 2017, Volume 65, Number 1, Page 172

DOI: 10.1007/s12026-016-8824-8

[7]

Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of etanercept

Francisca Llinares-Tello, José Rosas-Gómez de Salazar, José Miguel Senabre-Gallego, Gregorio Santos-Soler, Carlos Santos-Ramírez, Esteban Salas-Heredia, Juan Molina-García, and the AIRE-MB Group

Clinical Chemistry and Laboratory Medicine (CCLM), 2015, Volume 53, Number 10

DOI: 10.1515/cclm-2014-0898

[8]

Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentration

Céline Desvignes, Soujanya R Edupuganti, François Darrouzain, Anne-Claire Duveau, Amy Loercher, Gilles Paintaud, and Denis Mulleman

Bioanalysis, 2015, Volume 7, Number 10, Page 1253

DOI: 10.4155/bio.15.30

[9]

Infliximab drug and antibody levels in patients with dermatological conditions

L. Elberdín, M. Outeda, P. Salvador, S. Paradela, R. M. Fernández-Torres, R. Iglesias, E. Fonseca, and I. Martín

International Journal of Clinical Pharmacy, 2015, Volume 37, Number 2, Page 320

DOI: 10.1007/s11096-014-0062-3

[10]

Practical application of acid dissociation in monitoring patients treated with adalimumab

Francisca Llinares-Tello, José Rosas-Gómez de Salazar, José Miguel Senabre-Gallego, Gregorio Santos-Soler, Carlos Santos-Ramírez, Esteban Salas-Heredia, Xavier Barber-Vallés, and Juan Molina-García

Rheumatology International, 2014, Volume 34, Number 12, Page 1701

DOI: 10.1007/s00296-014-3032-0

[11]

Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis

Francisca Llinares-Tello, José Rosas, Inmaculada de la Torre, Lara Valor, Xavier Barber, and José Miguel Senabre

Reumatología Clínica (English Edition), 2014, Volume 10, Number 2, Page 105

DOI: 10.1016/j.reumae.2013.12.006

[12]

Estudio comparativo de las 2 versiones de un inmunoanálisis comercializado para la monitorización terapéutica de adalimumab en artritis reumatoide

Francisca Llinares-Tello, José Rosas, Inmaculada de la Torre, Lara Valor, Xavier Barber, and José Miguel Senabre

Reumatología Clínica, 2014, Volume 10, Number 2, Page 105

DOI: 10.1016/j.reuma.2013.07.007

Comments (0)

Please log in or register to comment.

General note: By using the comment function on degruyter.com you agree to our Privacy Statement. A respectful treatment of one another is important to us. Therefore we would like to draw your attention to our House Rules.

Recently viewed (1)

My CartAdded To Cart

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Most Downloaded Articles

Issues

Volume 58 (2020)

Volume 57 (2019)

Volume 56 (2018)

Volume 55 (2017)

Volume 54 (2016)

Volume 53 (2015)

Volume 52 (2014)

Volume 51 (2013)

Volume 50 (2012)

Volume 49 (2011)

Volume 48 (2010)

Volume 47 (2009)

Volume 46 (2008)

Volume 45 (2007)

Volume 44 (2006)

Volume 43 (2005)

Volume 42 (2004)

Volume 41 (2003)

Volume 40 (2002)

Volume 39 (2001)

Volume 38 (2000)

Volume 37 (1999)

Volume 36 (1998)

Volume 35 (1997)

Volume 34 (1996)

Volume 33 (1995)

Volume 32 (1994)

Volume 31 (1993)

Volume 30 (1992)

Volume 29 (1991)

Volume 28 (1990)

Volume 27 (1989)

Volume 26 (1988)

Volume 25 (1987)

Volume 24 (1986)

Volume 23 (1985)

Volume 22 (1984)

Volume 21 (1983)

Volume 20 (1982)

Volume 19 (1981)

Volume 18 (1980)

Volume 17 (1979)

Volume 16 (1978)

Volume 15 (1977)

Volume 14 (1976)

Volume 13 (1975)

Volume 12 (1974)

Volume 11 (1973)

Volume 10 (1972)

Volume 9 (1971)

Volume 8 (1970)

Volume 7 (1969)

Volume 6 (1968)

Volume 5 (1967)

Volume 4 (1966)

Volume 3 (1965)

Volume 2 (1964)

Volume 1 (1963)

Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab

About the article

Citing Articles

Related Content

Comments (0)

About De Gruyter

e-Products & Services

Imprints and Publisher Partners

Help & Contact Information

News